BIOMIMETIC THERAPEUTICS, INC. 4
4 · BIOMIMETIC THERAPEUTICS, INC. · Filed Jan 21, 2011
Insider Transaction Report
Form 4
BULLOCK LAWRENCE E
Chief Financial Officer
Transactions
- Award
Stock Options (right to buy)
2011-01-19+40,000→ 40,000 totalExercise: $13.45From: 2012-01-19Exp: 2021-01-19→ Common Stock (40,000 underlying)
Holdings
- 12,000(indirect: By Children)
Common Stock
- 66,608
Common Stock
Footnotes (3)
- [F1]The balance of common stock beneficially owned includes shares acquired by the Reporting Person since the 12/7/2010 Form 4 filing, consisting of 217 shares purchased through the Issuer's Employee Stock Purchase Plan for the 4th quarter 2010 and 771 shares awarded by Company match to the Reporting Person's 401(k) retirement account for 2010.
- [F2]Mr. Bullock disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.
- [F3]Options vest 25% each year on the anniversary of the 1/19/2011 grant date.